Skip to main content
Day.News — Local News. Real Community.
COLUMBUS DAY NEWS
Local News. Real Community.
health
1 min read

Study Examines At-Home Furosemide Treatment for Heart Failure Edema

A new study evaluated the use of at-home subcutaneous furosemide for treating edema related to heart failure. Researchers examined the safety and efficacy of patient self-treatment outside of a hospital setting.

06/11/2026 · Nevada edition

Advertisement

Advertisement

A recent clinical trial, known as SUBCUT HF II, investigated the use of at-home subcutaneous furosemide for patients experiencing edema related to heart failure. The study assessed whether patients could safely and effectively self-administer the medication outside of a hospital environment.

The trial met its primary and key secondary endpoints, according to researchers. These endpoints focused on evaluating both the safety and efficacy of the at-home treatment method. Study leaders presented the findings at a medical conference.

Furosemide is a medication that helps reduce fluid retention. Edema, the swelling caused by excess fluid, is a common symptom of heart failure and often requires medical intervention. Traditionally, patients experiencing significant edema require hospitalization for treatment.

Related Topics

Editorial Transparency
AI-Generated · Written by National Desk

Article Ratings

Factual
0.0
Likeable
0.0
Bias
0.0
Objective
0.0

How do you feel about this story?

NA

National Desk

Trust 3.1104047 articles8,231,170 views75% fact accuracy
View Profile

Sign in to follow this author from their profile.

Discussion (0)

Join the Conversation

Join the conversation

Sign in to share your thoughts, reply to readers, and like comments.

Sign in to comment
Sort by:
0 comments

No comments yet. Be the first to comment!

Trending Now

Trending stories will appear here.

More from Nevada

No other local stories are available right now.

Events & Things to Do

Read section →

Upcoming events will appear here.

Advertisement

Advertisement

Keep Reading

Related Stories

More health stories from Nevada

health

Transgender Inmates Challenge Federal Prison Policy on Healthcare Access

Attorneys representing transgender inmates have urged the Supreme Court to maintain a lower court's order. This order currently blocks the Federal Bureau of Prisons from enforcing a new policy restricting healthcare and social accommodations for transgender prisoners. The policy, implemented by the Trump administration, eliminates access to hormone therapy and items like makeup and wigs.

Read Story →
health

Government Review Examines Diagnoses of ADHD and Autism in Young People

A recent government review focused on younger individuals and their diagnoses of ADHD and autism. The report highlighted a shift in diagnostic patterns over time. Officials involved in the review acknowledged evolving societal and clinical approaches.

Read Story →
health

Discussion Addresses Mental Health, Suicide Trends in Black Community

NPR's Michel Martin hosted a panel discussion on mental health and suicide within the Black community. The conversation explored the subject through personal perspectives. Participants shared individual experiences.

Read Story →
health

FDA to Conclude Abortion Pill Safety Review by March

The Food and Drug Administration (FDA) will finalize its safety review of mifepristone in March. A Louisiana federal judge mandated this update as part of a legal challenge seeking to reverse a policy allowing mail delivery of the abortion medication.

Read Story →
health

GLP-1 Medications Show Potential in Addressing Addiction

New evidence suggests GLP-1 drugs, commonly used for diabetes and weight loss, may also reduce cravings for addictive substances. Scientists are conducting studies to determine if these medications can help individuals with substance use disorders. This research explores a potential new application for GLP-1s in public health.

Read Story →
health

Report Examines Impact of Trump Administration's Drug Pricing Initiatives

A recent report evaluated the Trump administration's claims regarding drug prices, including the effectiveness of TrumpRx discounts. Findings indicate a mixed impact on prescription drug costs for consumers. The administration has asserted that the U.S. now pays the world's lowest drug prices.

Read Story →
Scroll for more stories